World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
39465
World Ranking
2019
National Ranking
988

Medicine

D-Index
76
Citations
40537
World Ranking
18603
National Ranking
9266

Brian J. McMahon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Brian J. McMahon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 232 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Brian J. McMahon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian J. McMahon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Brian J. McMahon is affiliated with the Centers for Disease Control and Prevention in the United States. Their research focuses primarily on medicine, with a pronounced emphasis on epidemiology and hepatology, complemented by work in surgery, infectious diseases, and emergency medicine. The scientist's scholarly output includes 101 publications in medicine, with 42 specifically in epidemiology and 33 in hepatology.

Their research covers several core topics, including:

  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Viral gastroenteritis research and epidemiology
  • Ultrasound in Clinical Applications

Brian J. McMahon has contributed to multiple papers with notable examples published between 2020 and 2023. These include:

  • "Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018" (2022, Hepatology)
  • "WGO Guidance for the Care of Patients With COVID-19 and Liver Disease" (2020, Journal of Clinical Gastroenterology)
  • "HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study" (2021, Hepatology)
  • "Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose" (2022, Hepatology)
  • "Opportunities to address gaps in early detection and improve outcomes of liver cancer" (2023, JNCI Cancer Spectrum)

The scientist's frequent collaborators include Chriss Homan, Janet M. Johnston, Dana Bruden, Michael G. Bruce, and Lisa Townshend-Bulson. Collaboration has often occurred with these colleagues across numerous publications.

Brian J. McMahon regularly publishes work in journals such as Hepatology, Journal of Viral Hepatitis, SSRN Electronic Journal, Gastroenterology, and Hepatology Communications. The highest number of contributions appear in Hepatology with five publications.

Best Publications

  • Chronic hepatitis B

    Anna Suk-Fong Lok;Brian J. McMahon

  • Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

    Norah A. Terrault;Anna S.F. Lok;Brian J. McMahon;Kyong Mi Chang

  • Chronic hepatitis B: Update 2009

    Anna S. F. Lok;Brian J. McMahon

  • The Global Burden of Cancer 2013

    Christina Fitzmaurice;Christina Fitzmaurice;Daniel Dicker;Daniel Dicker;Amanda Pain;Hannah Hamavid

  • Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration

    Christina Fitzmaurice;Christina Fitzmaurice;Tomi F. Akinyemiju;Faris Hasan Al Lami;Tahiya Alam

  • The natural history of chronic hepatitis B virus infection.

    Brian J. McMahon

  • Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier State

    Brian J. McMahon;Wallace L. M. Alward;David B. Hall;William L. Heyward

  • Chronic hepatitis B: update of recommendations.

    Anna S.F. Lok;Brian J. McMahon

  • Epidemiology and natural history of hepatitis B.

    Brian J. McMahon

  • Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis

    Anna S.F. Lok;Brian J. McMahon;Robert S. Brown;John B. Wong

  • Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

    Brian J. McMahon;Peter Holck;Lisa Bulkow;Mary Snowball

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells

    Lucy Golden-Mason;Brent E. Palmer;Nasim Kassam;Lisa Townshend-Bulson

  • Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up

    Brian J McMahon;Dana L Bruden;Kenneth M Petersen;Lisa R Bulkow

  • Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

    Rachel H. McMahan;Lucy Golden-Mason;Michael I. Nishimura;Brian J. McMahon

  • Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.

    Brian J. McMahon;Steven R. Alberts;Robert B. Wainwright;Lisa Bulkow

  • Chronic hepatitis B

    Unknown

  • Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis

    Robert S. Brown;Brian J. McMahon;Anna S.F. Lok;John B. Wong

  • Present and future therapies of hepatitis B: From discovery to cure

    T. Jake Liang;Timothy M. Block;Brian J. McMahon;Marc G. Ghany

  • Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

    Josephine Simonetti;Lisa Bulkow;Brian J. McMahon;Brian J. McMahon;Chriss Homan

  • Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

    Emmet B. Keeffe;Sten Iwarson;Brian J. McMahon;Karen L. Lindsay

  • Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease

    Unknown

Frequent Co-Authors

Lisa R. Bulkow
Lisa R. Bulkow Centers for Disease Control and Prevention
Thomas W. Hennessy
Thomas W. Hennessy Centers for Disease Control and Prevention
Alan J. Parkinson
Alan J. Parkinson Centers for Disease Control and Prevention
David R. Gretch
David R. Gretch University of Washington
Juan Sanabria
Juan Sanabria Marshall University
Bach Xuan Tran
Bach Xuan Tran Vietnam National University, Hanoi
Ted R. Miller
Ted R. Miller Pacific Institute
Simon I. Hay
Simon I. Hay University of Washington
Shafiu Mohammed
Shafiu Mohammed Ahmadu Bello University
Gholamreza Roshandel
Gholamreza Roshandel Golestan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open doors to diverse healthcare roles. Many students pursue accelerated paths like the 12-month accelerated nursing programs, which are designed for faster entry into nursing careers while building a strong foundation in patient care and clinical skills.

Entry-level options such as the easiest LPN programs to get into provide practical training that complements immunological expertise with hands-on nursing duties. These programs often offer flexible online formats, making it easier for students to balance studies and personal commitments.

For those aiming to advance in clinical roles, the easiest nurse practitioner degree programs offer streamlined pathways to gain higher qualifications. These programs emphasize advanced practice skills relevant to immunology-related patient care.

Specialized tracks like psychiatric mental health nurse practitioner training are also relevant, especially with regard to immune system impacts on mental health. Prospective students can explore the best PMHNP programs for quality clinical placements that ensure real-world experience.

Best Scientists Citing Brian J. McMahon

Trending Scientists

Recently Published Articles